Clinical Laserthermia Systems AB (publ)
Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. It offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. The company also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers that provides multiple options to control trea… Read more
Market Cap & Net Worth: Clinical Laserthermia Systems AB (publ) (CLS-B)
Clinical Laserthermia Systems AB (publ) (ST:CLS-B) has a market capitalization of $15.45 Million (Skr173.29 Million) as of March 19, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #27131 globally and #360 in its home market, demonstrating a 2.02% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Clinical Laserthermia Systems AB (publ)'s stock price Skr5.56 by its total outstanding shares 31166594 (31.17 Million).
Clinical Laserthermia Systems AB (publ) Market Cap History: 2015 to 2026
Clinical Laserthermia Systems AB (publ)'s market capitalization history from 2015 to 2026. Data shows change from $1.23 Billion to $15.45 Million (-35.53% CAGR).
Clinical Laserthermia Systems AB (publ) Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Clinical Laserthermia Systems AB (publ)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.09x
Clinical Laserthermia Systems AB (publ)'s market cap is 1.09 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.38 Billion | $3.64 Million | -$26.95 Million | 379.60x | N/A |
| 2017 | $2.15 Billion | $614.45K | -$21.26 Million | 3502.29x | N/A |
| 2018 | $981.15 Million | $1.81 Million | -$32.85 Million | 542.67x | N/A |
| 2019 | $842.54 Million | $1.43 Million | -$43.38 Million | 590.84x | N/A |
| 2020 | $651.69 Million | $1.33 Million | -$57.94 Million | 489.26x | N/A |
| 2021 | $597.83 Million | $2.25 Million | -$63.62 Million | 266.29x | N/A |
| 2022 | $147.86 Million | $6.27 Million | -$70.66 Million | 23.59x | N/A |
| 2023 | $76.68 Million | $8.27 Million | -$79.79 Million | 9.27x | N/A |
| 2024 | $10.17 Million | $18.78 Million | -$47.62 Million | 0.54x | N/A |
| 2025 | $19.11 Million | $17.49 Million | -$41.61 Million | 1.09x | N/A |
Competitor Companies of CLS-B by Market Capitalization
Companies near Clinical Laserthermia Systems AB (publ) in the global market cap rankings as of March 19, 2026.
Key companies related to Clinical Laserthermia Systems AB (publ) by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Clinical Laserthermia Systems AB (publ) Historical Marketcap From 2015 to 2026
Between 2015 and today, Clinical Laserthermia Systems AB (publ)'s market cap moved from $1.23 Billion to $ 15.45 Million, with a yearly change of -35.53%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr15.45 Million | -19.19% |
| 2025 | Skr19.11 Million | +87.98% |
| 2024 | Skr10.17 Million | -86.74% |
| 2023 | Skr76.68 Million | -48.14% |
| 2022 | Skr147.86 Million | -75.27% |
| 2021 | Skr597.83 Million | -8.27% |
| 2020 | Skr651.69 Million | -22.65% |
| 2019 | Skr842.54 Million | -14.13% |
| 2018 | Skr981.15 Million | -54.41% |
| 2017 | Skr2.15 Billion | +55.87% |
| 2016 | Skr1.38 Billion | +11.90% |
| 2015 | Skr1.23 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Clinical Laserthermia Systems AB (publ) was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $15.45 Million USD |
| MoneyControl | $15.45 Million USD |
| MarketWatch | $15.45 Million USD |
| marketcap.company | $15.45 Million USD |
| Reuters | $15.45 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.